Valneva SE (INRLF)
3.29
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Valneva Price to Book Value : 6.728 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 6.728 |
| August 26, 2026 | 6.728 |
| August 25, 2026 | 6.728 |
| August 24, 2026 | 6.728 |
| August 21, 2026 | 6.728 |
| August 20, 2026 | 7.049 |
| August 19, 2026 | 7.049 |
| August 18, 2026 | 7.049 |
| August 17, 2026 | 7.049 |
| August 14, 2026 | 7.049 |
| August 13, 2026 | 4.959 |
| August 12, 2026 | 4.959 |
| August 11, 2026 | 4.959 |
| August 10, 2026 | 4.959 |
| August 07, 2026 | 4.959 |
| August 06, 2026 | 4.959 |
| August 05, 2026 | 4.959 |
| August 04, 2026 | 4.959 |
| August 03, 2026 | 4.959 |
| July 31, 2026 | 4.959 |
| July 30, 2026 | 4.959 |
| July 29, 2026 | 5.357 |
| July 28, 2026 | 5.357 |
| July 27, 2026 | 5.357 |
| July 24, 2026 | 5.357 |
| Date | Value |
|---|---|
| July 23, 2026 | 5.357 |
| July 22, 2026 | 5.357 |
| July 21, 2026 | 5.357 |
| July 20, 2026 | 5.357 |
| July 17, 2026 | 5.357 |
| July 16, 2026 | 5.357 |
| July 15, 2026 | 5.357 |
| July 14, 2026 | 5.357 |
| July 13, 2026 | 5.357 |
| July 10, 2026 | 5.357 |
| July 09, 2026 | 5.357 |
| July 08, 2026 | 5.357 |
| July 07, 2026 | 5.357 |
| July 06, 2026 | 5.357 |
| July 02, 2026 | 5.357 |
| July 01, 2026 | 5.357 |
| June 30, 2026 | 5.357 |
| June 29, 2026 | 5.102 |
| June 26, 2026 | 5.102 |
| June 25, 2026 | 5.102 |
| June 24, 2026 | 4.871 |
| June 23, 2026 | 4.871 |
| June 22, 2026 | 5.024 |
| June 18, 2026 | 5.024 |
| June 17, 2026 | 5.024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 3.843 |
| Cellectis SA | 8.411 |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.489 |
| PEG Ratio | -0.0233 |
| Price | 3.29 |
| Earnings Yield | -31.82% |
| Market Cap | 623.94M |
| PEGY Ratio | -0.0233 |